Markets
Stocks
Mutual Funds & ETF's
Sectors
Rates
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
AMYLIN PHARMACEUTIC (NQ: AMLN)
+0.3500 (+1.671%)
at
21.29 USD
369,944 in Volume
Add to:
My Watchlist
Data as of 12:15 PM EDT Sep 2, 2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Today's Open 21.00
Bid (Size) 21.29 (100)
Ask (Size) 21.30 (300)
Prev. Close 20.94
Today's Range 20.74 - 21.48
52wk Range 11.01 - 24.21
Shares Outstanding 143,672,976
Morningstar Profile
View Full Profile
AMYLIN PHARMACEUTIC
Amylin Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of innovative medicines for the treatment of diabetes, obesity and other diseases.
Healthcare
Biotechnology
Exchange Traded NQ
Market Cap 3.06B
Related Companies OSIP IDXX QGEN UTHR
Top News
Read More
Orexigen Fattens Its Coffers With Takeda Cash   
11:50 EDT
Orexigen Therapeutics (OREX) finally becomes a major competitor in the race to get an obesity drug on the market. The oft-in-the-shadows biotech has garnered a pair-up with Japan's Takeda... Read More
from Minyanville
SmarTrend Watching for Pullback in Shares of Amylin Pharmaceuticals After 1.95% Gain (AMLN)   
3:38 EDT
from Comtex SmarTrend® News Briefs
More News
Read More
Pipeline Review: Bristol-Myers Squibb's 5 Keys to Success   
Sep 01, 2010
from Fool.com Headlines
Interesting Options Volume for Amylin Pharmaceuticals (AMLN)   
Sep 01, 2010
from MarketIntellisearch.com
Barclays Maintains an 'Overweight' Rating on Amylin Pharmaceuticals (AMLN); TRx Share Continues to Increase Byetta Losing Share in GLPs   
Aug 31, 2010
from StreetInsider.com News Articles
Daily Options Trading for Amylin Pharmaceuticals (AMLN)   
Aug 31, 2010
from MarketIntellisearch.com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Bots go here
© Copyright FinancialContent, Inc.